Baird Medical Investment Holdings Limited
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $33.4M
- Price
- $0.79
- % Change (Daily % change from the live per-ticker quote feed.)
- 0.00%
- Volume
- 67.0K
About
Based in China, Baird Medical Investment Holdings Limited and its associated entities specialize in engineering and commercializing microwave ablation medical apparatus. These sophisticated instruments are employed in the minimally invasive management of a diverse array of benign and malignant tumors, notably targeting thyroid nodules, hepatic carcinomas, pulmonary cancers, and mammary lesions. The organization was established in 2012, with its corporate headquarters situated in Guangzhou, China.
Quick stats
Shares outstanding42.3M
Computed float6.5M
Float / shares15.3%
Key info
SectorHealthcare
IndustryMedical - Devices
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001982444
Websitehttps://www.bairdmed.com
AI Summary
AI-generated1/18
minorbullishoperations update
Baird Medical Highlights Global Expansion and Strategic Progress During Third Quarter 2026
Baird Medical highlighted Q3 2026 progress including registrations from Pakistan's DRAP for its BD-GT MWA system and T-1610 needle, opening the Pakistani market.
First MWA procedures were completed in Vietnam and Argentina, and an August strategic partnership with Alpmed added irreversible electroporation technology to its minimally invasive portfolio.
Management also presented at H.C. Wainwright and expanded physician training programs in the U.S. and China; no financial figures or guidance were disclosed.